Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Board Changes

26 May 2016 07:00

RNS Number : 3384Z
Mercia Technologies PLC
26 May 2016
 

FOR IMMEDIATE RELEASE

26 May 2016

 

Mercia Technologies PLC

"Mercia" or "the Group"

 

Board Changes

 

Mercia Technologies PLC (AIM: MERC), which is focused on the creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, announces that Ray Chamberlain, the Group's current Non-executive Chair has decided that having recently reached 70 years of age now is the appropriate time for him to step down from his role, whilst remaining a Non-executive Director. Susan Searle, currently Non-executive Deputy Chair of the Group, has been appointed as the new Non-executive Chair.

 

As a consequence of Susan's appointment, there are a number of changes to the composition of the Audit, Nominations and Remuneration Committees. Martin Lamb will become Chair of the Audit Committee, Susan Searle will become Chair of the Nominations Committee and Ian Metcalfe will remain Chair of the Remuneration Committee. All four Non-executive Directors will also now sit on all three committees.

 

Mark Payton, Chief Executive Officer of Mercia, commented:

 

"On behalf of the Board, I would like to thank Ray for his significant contribution to the creation and development of Mercia Technologies to date. As a successful and long standing technology investor he has played an instrumental role in the establishment and successful flotation of our Group and I am delighted that he will remain a key member of our Non-executive team.

 

Susan joined the Board of Mercia at the time of the Group's flotation in December 2014, bringing in-depth sector experience and expertise, having previously been the founder and Chief Executive Officer of Imperial Innovations Group plc. She has demonstrated a natural understanding of all aspects of Mercia's business model and her insights continue to prove invaluable as Mercia executes its growth strategy.

 

These changes provide strong continuity of leadership for the Board and I look forward to continuing to work with Susan as Chair and Ray as a Non-executive Director going forward."

 

 

For further information, please contact:

Mercia Technologies PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatechnologies.com

 

+44 (0)330 223 1430

 

Cenkos Securities plc

Ivonne Cantu / Mark Connelly (NOMAD)

+44 (0)20 7397 8900

Buchanan

Sophie McNulty, Victoria Watkins, Stephanie Watson

www.buchanan.uk.com

+44 (0)20 7466 5000

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the creation, funding and scaling of innovative businesses with high growth potential from the UK regions. Mercia benefits from 14 university partnerships and six offices across the Midlands, the North of England and Scotland, providing it with access to high quality, regional deal flow. Mercia is quoted on AIM with the epic "MERC".

 

Mercia's "complete capital solution" investment model initially nurtures businesses via its third party funds under management (expanded to circa £220 million following its acquisition of Enterprise Ventures Group) and then over time Mercia can provide further funding to its emerging stars thanks to its ability to deploy direct investment follow-on capital from its own balance sheet.

 

In a recent report (Source: Beauhurst, The Deal, 2015/16), Mercia was found to be the fifth most active investor in the UK and the fourth most active in technology. Since its IPO in December 2014, the Company has invested over £20 million directly across its portfolio of emerging stars and continues to seek both early stage third party investment opportunities as well as providing its emerging stars with the required capital and management support to build towards exits that will realise incremental value for Mercia shareholders.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAAKPDQOBKDPPB
Date   Source Headline
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.